(Q53961036)
Statements
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2 (English)
C. F. LeMaistre
M. N. Saleh
T. M. Kuzel
F. Foss
L. C. Platanias
G. Schwartz
M. Ratain
A. Rook
C. O. Freytes
F. Craig
J. Reuben
1 January 1998
15 January 1998